# Molecular Classification of Endometrial Cancer: Impact on Adjuvant Treatment Planning.

> **NCT06584630** · — · ACTIVE_NOT_RECRUITING · sponsor: **Aristotle University Of Thessaloniki** · enrollment: 80 (estimated)

## Conditions studied

- Endometrial Cancer

## Interventions

_None listed._

## Key facts

- **NCT ID:** NCT06584630
- **Lead sponsor:** Aristotle University Of Thessaloniki
- **Sponsor class:** OTHER
- **Phase:** —
- **Study type:** OBSERVATIONAL
- **Status:** ACTIVE_NOT_RECRUITING
- **Start date:** 2022-01-01
- **Primary completion:** 2024-12-31
- **Final completion:** 2025-12-31
- **Target enrollment:** 80 (ESTIMATED)
- **Last updated:** 2024-09-19


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT06584630

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT06584630, "Molecular Classification of Endometrial Cancer: Impact on Adjuvant Treatment Planning.". Retrieved via AI Analytics 2026-05-28 from https://api.ai-analytics.org/clinical/NCT06584630. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*